Recent Press Releases

Evotec receives milestone payment as part of its discovery alliance with Boehringer Ingelheim

Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a...

ClinicalRM and Ohio Clinical Trials Collaborative Launch Partnership

CLEVELAND--ClinicalRM, Inc. and the Ohio Clinical Trials Collaborative (OCTC) announce a co-marketing partnership offering joint services for clinical trials of new biologics, drugs and medical...

Bristol-Myers Squibb Expands Access to Clinical Trial Data Through Collaboration with Academic Research Institute

NEW YORK--Bristol-Myers Squibb (NYSE:BMY) today announced a collaboration with Duke University through its Duke Clinical Research Institute (DCRI) focused on clinical trial transparency....

PAREXEL International Issues Earnings Guidance in Conjunction with Investor Day

Boston, MA – In conjunction with its Investor Day being held tomorrow, PAREXEL International Corporation (Nasdaq: PRXL) has reconfirmed its forward-looking guidance for the fourth quarter of...

COVANCE MARKETPLACE, A NEW SOLUTION TO EXPEDITE BIOPHARMACEUTICAL DEVELOPMENT

Princeton, N.J. – Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company and a leader in nutritional analysis, today announced the introduction of Covance...

ABF Pharmaceutical Services GmbH announces the new appointment of President of Commercial Operations

ABF Pharmaceutical Services GmbH announces the appointment of Ms Maxime Stevens as President of Commercial Operations, tasked with the responsibility of strategically growing and aligning the...

Teva Reaches Settlement in ProAir® HFA Patent Case

ERUSALEM, Jun 20, 2014 (BUSINESS WIRE) -- Teva Pharmaceutical Industries Ltd. announced that it has reached a settlement with Perrigo Pharmaceutical Co. and Catalent Pharma Solutions LLC with respect...

PAREXEL Cuts Clinical Trial Start-Up Time for Sponsors by Weeks with New Version of Industry-Leading Clinphone® RTSM Services

Latest RTSM technology features standardized study components for faster implementation and greater design flexibility BOSTON, MA – PAREXEL International (NASDAQ: PRXL), a leading global...

Merger of Simbec & ORION to Create a New International Full-Service CRO

Highlights: · Creation of an international CRO with complete service offering from Phase I to Phase IV post-authorisation studies · Appointment of a highly experienced...

Japan's CROee to Establish US-based Clinical Trial Recruitment Company with BBK Worldwide

SAN DIEGO and BOSTON -- DIA 2014 50th Annual Meeting -- BBK Worldwide, a leading clinical trial marketing firm, and CROee, the first consulting Japanese CRO specializing in patient recruitment, today...

Quintiles and Modern Marketing Concepts Collaborate to Launch Innovative Marketing Analytics Platform

RESEARCH TRIANGLE PARK, N.C. & BINGHAMTON, N.Y.--Quintiles and Modern Marketing Concepts (MMC, Inc.) today announced the launch of a new marketing analytics platform that enables Quintiles to...

BioClinica Acquires Blueprint Clinical, Inc.

NEWTOWN, Pa.--BioClinica®, Inc ., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering...

Parexel International Announces $150 Million Accelerated Share Repurchase Program

BOSTON, June 16, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that it has entered into an Accelerated Share Repurchase (ASR) agreement with Goldman Sachs...

Actinium Engages a Leading CRO to Support Phase 3 Trial of Iomab-B

NEW YORK, Jun 16, 2014 (BUSINESS WIRE) -- Actinium Pharmaceuticals, Inc . ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Cellectis and Accelera (Nerviano Medical Sciences Group) Sign an Agreement to Complete Preclinical Studies of Cellectis' Lead Product Candidate UCART19

Cellectis (Paris:ALCLS), a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed...

PRA Advances to Become PRA Health Sciences

RALEIGH, N.C., June 16, 2014 -- PRA, a leading clinical research organization, today announced that it has changed its name to PRA Health Sciences (PRA). The name change to PRA Health Sciences is the...

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

San Diego, CA | Novotech, Australia's largest clinical CRO with offices throughout Asia, has signed an MOU with the Korea Drug Development Fund (KDDF) to promote the development of the Korean...

Quintiles and American Physical Therapy Association Announce Plans to Develop New Outcomes Registry

RESEARCH TRIANGLE PARK, N.C. and ALEXANDRIA, Va. – Quintiles and the American Physical Therapy Association (APTA) today announced a new strategic collaboration to develop and implement the...

Veristat and Karyopharm Therapeutics Inc. Enter into Preferred Provider Agreement for Oncology and Novel Therapeutic Advancement

HOLLISTON, Mass.--Veristat, a full service Contract Research Organization, announced today that Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the...

Oncobiologics launches Phase I Clinical Trial for ONS-3010 Biosimilar version of Humira®

CRANBURY, N.J. -- Oncobiologics, Inc. announced today that it has received approval to initiate a Phase I clinical trial in Europe for its first biosimilar molecule, ONS-3010, a highly biosimilar...